Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Retrospective Analysis of Prognostic Factors Associated With Response and Overall Survival by Baseline Marrow Blast Percentage in Patients With Myelodysplastic Syndromes Treated With Decitabine.

    ... vs. 16% high-risk patients), and lower median baseline platelet count (62.3 vs. 112.7 × 103/μL) vs. patients with MDS (n = 157), ...

    Research Article last updated 06/28/2013 - 1:20pm.

  2. Thrombosis in paroxysmal nocturnal hemoglobinuria.

    ... will be discussed. Mechanisms explored include platelet activation, toxicity of free hemoglobin , nitric oxide ...

    Research Article last updated 05/14/2013 - 3:29pm.

  3. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.

    ... UD). All patients showed neutrophil and platelet engraftment . Cumulative incidence of acute (grade 2 or ...

    Research Article last updated 05/14/2013 - 1:00pm.

  4. Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study

    ... time was 142 days. In patients treated with BSC, platelet count alone was an independent prognostic factor. In younger ...

    Research Article last updated 04/02/2013 - 7:59am.

  5. Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine.

    ... to AML. A hemoglobin value at least 10 g/dL, platelet count at least 50 × 10(3)/μL, and lack of chromosome 5 or 7 ...

    Research Article last updated 01/02/2013 - 2:53pm.

  6. Cotransplantation of allogeneic mesenchymal and hematopoietic stem cells in children with aplastic anemia

    ... × 10(6)/kg). The mean time for neutrophil and platelet recovery was 12.3 and 13.8 days, respectively. Acute GvHD grade I ...

    Research Article last updated 07/30/2012 - 1:18pm.

  7. HLA-Matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft-versus-Host Disease, and Overall Survival.

    ... = .01). However, neutrophil recovery at day -28, platelet recovery at day -100, acute GVHD, chronic GVHD, and overall ...

    Research Article last updated 06/15/2012 - 2:55pm.

  8. Asymptomatic cerebral bleeds in patients with aplastic anemia.

    ... gm/dl), white cell count 2,320/μl (800-7,000/μl), and platelet count 11,500/μl (7000-45,000/μl). Three patients were detected ...

    Research Article last updated 06/15/2012 - 2:46pm.

  9. Therapy for aplastic anemia

    ... registry, including cord blood. He is red cell- and platelet transfusion -dependent. He has been recommended therapy with ...

    Research Article last updated 01/09/2012 - 10:58am.

  10. The long term risk of myelodysplastic syndromes among anemia patients: A population-based study.

    ... white blood cell count of less than 3500/mm(3), and platelet count of less than 100×10(9)/L were associated with a ...

    Research Article last updated 12/12/2011 - 9:55am.